abstract |
The present invention provides novel thienopyrimidine compounds of formula (I), pharmaceutical compositions comprising such compounds, and those that may be affected by inhibiting the kinase activity of Mnk1 and / or Mnk2 (Mnk2a or Mnk2b) and / or variants thereof. It relates to its therapeutic use for the prevention and / or treatment of a disease. Formula I |